| Title | Effect of persistent moderate viremia on disease progression during HIV therapy. |
| Publication Type | Journal Article |
| Year of Publication | 2004 |
| Authors | Raffanti, Stephen P., Jennifer S. Fusco, Beth H. Sherrill, Nellie I. Hansen, Amy C. Justice, Richard D'Aquila, Wendy J. Mangialardi, and Gregory P. Fusco |
| Corporate Authors | Collaborations in HIV Outcomes Research/United States Project |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 37 |
| Issue | 1 |
| Pagination | 1147-54 |
| Date Published | 2004 Sep 1 |
| ISSN | 1525-4135 |
| Keywords | Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Disease Progression, Drug Therapy, Combination, Female, HIV Infections, HIV-1, Humans, Male, Proportional Hazards Models, Reverse Transcriptase Inhibitors, RNA, Viral, United States, Viral Load, Viremia |
| Abstract | Although highly active antiretroviral therapy has been shown to lower plasma HIV-1 RNA in HIV infection, many patients do not reach the target goal of undetectable viremia. We evaluated whether risk of clinical progression varies by level of viral suppression achieved. |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
